naratriptan (Zosano Pharma)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug Namenaratriptan (Zosano Pharma)
Drug Alias Namenaratriptan
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin 1d (5-HT1d) receptor agonistsSerotonin 1b (5-HT1b) receptor agonists
TargetsSerotonin 1d (5-HT1d) receptorSerotonin 1b (5-HT1b) receptor
Therapy Area/Indications +[1]  N/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesZosano Pharma Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesZosano Pharma Corp
Active IndicationsN/A
Inactive Indications +[1]  N/A

Other Information

ATC CodeN/A
Related LinksN/A